Age-Related Macular Degeneration
and
Retinal Vascular Diseases 2009:
An Intensive Review
Jointly sponsored by
Tufts University School of Medicine
and New England Eye Center
Sackler Auditorium
Tufts University School of Medicine
Boston, Massachusetts
Saturday, September 26, 2009
Target Audience:
Vitreoretinal practitioners
Program Goal:
This symposium is designed to update practicing clinicians on the clinical indications and new therapies for age-related macular degeneration and retinal vascular diseases.
Educational Objectives:
At the conclusion of the program, participants will be able to:
- Identify emerging therapies for retinal vascular diseases including retinal venous obstruction and diabetic retinopathy.
- Identify emerging therapies in the treatment of age-related macular degeneration.
- Describe effective evaluation and follow-up strategies for patients with AMD and retinal vascular conditions
- Discuss the pathophysiology and pathways of these new treatments.
- Identify ways to integrate these new treatments into clinical practice
(This program is designed to address the following ABMS/IOM competencies: Medical knowledge, Patient care, Systems-based practice, Practice-based learning and improvement, Provide patient-centered care, and Employ evidence-based practice.)
Disclosure:
Disclosure information from faculty and all other persons in control of content will be provided to participants prior to the beginning of the educational activity.
Commercial Support and Exhibitors:
A list of commercial supporters and exhibitors will be provided to participants in program materials.
Non Endorsement Statement:
The content and views presented in this educational activity are those of the faculty and do not necessarily reflect the opinions or recommendations of the Tufts University School of Medicine or New England Eye Center. Inclusion in this activity does not constitute approval or endorsement of any commercial products or services. These materials have been prepared based on the best available information, but are not exhaustive of the subject matter. Participants are advised to critically appraise the information presented and encouraged to consult the available literature for any commercial products mentioned.
Accreditation Statement:
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Tufts University School of Medicine (TUSM) and New England Eye Center. TUSM is accredited by the ACCME to provide continuing medical education for physicians.
TUSM designates this educational activity for a maximum of 5.5 AMA PRA Category 1 Credits™. To receive CE credit, participants must sign-in, attend the entire program and complete a program evaluation. Certificates will be mailed within 4-6 weeks after the program.
ADA/OEO Nondiscrimination Policy:
Tufts University School of Medicine (TUSM) considers all applicants and program participants without regard to race, color, national origin, age, religious creed, sex or sexual orientation. TUSM is an Equal Opportunity Employer. Please let us know in advance if you require any accommodations.
TUSM does not discriminate on the basis of a disability in admissions, access to treatment, or employment in their programs and activities as identified in the Americans with Disabilities Act.
Policy On Privacy And Confidentiality:
Click here to view TUSM OCE privacy policy. For questions, please contact Tufts University School of Medicine-Office of Continuing Education at med-oce@tufts.edu or 617-636-6579.
Program Agenda
| 7:00-8:00AM | Registration and Continental Breakfast |
Session I
8:00-8:05AM |
Welcome and Introduction |
8:06-8:26AM |
The Potential Role of Nutrition in Retinal Vascular Disorders |
8:27-8:47AM |
Modifiable Risk Factors for Retinal Vascular Disease |
8:48-9:08AM |
Corticosteroids VS. Laser Treatment |
9:09-9:29AM |
SCORE Trial Results |
9:30-9:45AM |
Combined Therapies for Retinal Vascular Disease |
9:46-10:06AM |
Q&A |
10:07-10:27AM |
Break |
Session II
10:28-10:40AM |
Overview of Maintenance Phase Paradigms |
10:41-11:01AM |
Gene Therapy for Retinal Diseases |
11:02-11:22AM |
OCT as a Tool in Determining Retreatment |
11:23-11:43AM |
Brachytherapy for AMD |
11:44-12:04PM |
Anti-PDGF and Anti-C5 for AMD |
12:05-12:25PM |
New Treatments for Retinal Disorders |
12:26-12:46PM |
Q&A |
12:47-2:00PM |
Lunch and Round Table Discussions |
Course Director
Elias Reichel, MD |
Associate Professor of Ophthalmology |
Visiting Faculty
Michael S. Ip, MD |
Associate Professor |
James A. Joseph, PhD |
Director, Neuroscience Laboratory |
Samir Patel. MD |
President and CEO |
Carmen A. Puliafito, MD, MBA |
Dean, Keck School of Medicine |
Carl D. Regillo, MD, FACS |
Professor of Ophthalmology |
Additional NEEC Faculty
Caroline R. Baumal, MD |
Assistant Professor |
Jay S. Duker, MD |
Director, New England Eye Center |
Rajendra Kumar-Singh, PhD |
Associate Professor of Ophthalmology |
Johanna M. Seddon, MD, ScM |
Professor of Ophthalmology |
REGISTRATION
Course Fee:
$200 USD
You may pay by check or credit card (Amex, Mastercard or Visa)
Send:
Name
Address
Phone
E-mail
Payment
Fax:
(617-636-4215)
Mail:
Stephanie Dunn,
New England Eye Center
800 Washington St., #450
Boston, MA 02111
Call:
617-636-4677
Cancellation/Refund:
Registrants may cancel up to August 28, 2009 for a refund minus a $25 administration fee. Cancellation after August 28, 2009 and/or a “no-show” will not qualify for a refund. In the event the organization must cancel this course, the registrant will receive a full refund.
